Managers / Q3 2021 · view latest →
Telemetry Investments, L.L.C.
CIK 0001537055 · 152 WEST 36TH STREET, ROOM 402, NEW YORK, NY, 10018-8765 · 212-425-9700
Reported Value
$74M
Q3 2021
Positions
160
Filings on Record
17
2019–present window
Filed
Nov 15, 2021
original filing
Summary
Telemetry Investments, L.L.C. reported $74M in U.S.-listed holdings across 160 positions for Q3 2021.
Its largest position, IWM, represents 4.5% of the portfolio.
Compared with Q2 2021, the fund opened 67 new positions and exited 46.
Portfolio Metrics
Turnover
+43.2%
vs prior filed quarter
Top-10 Concentration
+28.0%
share of reported value
Largest Position
+4.5%
Ishares Tr
New / Exited
67 / 46
positions this quarter
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
13F Reported Value
Portfolio Composition
By security type
- Common Stock · 45.9% · $34M
- Other · 37.7% · $28M
- ETP · 8.2% · $6M
- ADR · 3.7% · $3M
- REIT · 2.7% · $2M
- Other · 1.8% · $1M
Quarter-over-Quarter Changes full breakdown →
vs Q2 2021 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| ANGEL POND HOLDINGS CORP | NEW | +300.7K | 300.7K | +$3M | $3M |
| HEALTHWELL ACQUISITION CORP | NEW | +216.7K | 216.7K | +$2M | $2M |
| STONEBRIDGE ACQUISITION CORP | NEW | +182.8K | 182.8K | +$2M | $2M |
| IWMISHARES TR | NEW | +7.0K | 7.0K | +$2M | $2M |
| STMPSTAMPS COM INC | NEW | +4.5K | 4.5K | +$1M | $1M |
| MDLAMEDALLIA INC | NEW | +38.8K | 38.8K | +$1M | $1M |
| FUTURE HEALTH ESG CORP | NEW | +100.0K | 100.0K | +$1M | $1M |
| STATE AUTO FINL CORP | NEW | +19.2K | 19.2K | +$979,000 | $979,000 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q3 2021
144 positions
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | IWMISHARES TR | RUSSELL 2000 ETF · CHINA LG-CAP ETF · MSCI INDIA ETF · MSCI EURO FL ETF · MSCI EMG MKT ETF | 4.50% | $3M | 57.5K |
| 2 | ANGEL POND HOLDINGS CORP | SHS CL A · *W EXP 99/99/999 | 4.02% | $3M | 403.8K |
| 3 | SILVER SPIKE ACQUISITN CORP | CLASS A ORD SHS · *W EXP 02/26/202 | 3.78% | $3M | 336.2K |
| 4 | HEALTHWELL ACQUISITION CORP | UNIT 08/05/2028 | 2.87% | $2M | 216.7K |
| 5 | STONEBRIDGE ACQUISITION CORP | UNIT 04/11/2026 | 2.48% | $2M | 182.8K |
| 6 | XILINX INC | COM | 2.24% | $2M | 11.0K |
| 7 | VERVEREIT INChistory → | COM | 2.23% | $2M | 36.6K |
| 8 | ATYRATYR PHARMA INChistory → | COM NEW | 2.02% | $2M | 165.3K |
| 9 | STMPSTAMPS COM INChistory → | COM NEW | 1.98% | $1M | 4.5K |
| 10 | IHS MARKIT LTD | SHS | 1.89% | $1M | 12.0K |
| 11 | FCXFREEPORT-MCMORAN INChistory → | CL B | 1.80% | $1M | 41.0K |
| 12 | MDLAMEDALLIA INChistory → | COM | 1.77% | $1M | 38.8K |
| 13 | EIGER BIOPHARMACEUTICALS INC | COM | 1.76% | $1M | 195.1K |
| 14 | PARATEK PHARMACEUTICALS INC | COM | 1.59% | $1M | 242.5K |
| 15 | WTWWILLIS TOWERS WATSON PLC LTDhistory → | SHS | 1.47% | $1M | 4.7K |
| 16 | DISDISNEY WALT COhistory → | COM | 1.46% | $1M | 6.4K |
| 17 | COHERENT INC | COM | 1.41% | $1M | 4.2K |
| 18 | FUTURE HEALTH ESG CORP | UNIT 09/09/2026 | 1.35% | $1M | 100.0K |
| 19 | CCITIGROUP INChistory → | COM NEW | 1.33% | $986,000 | 14.0K |
| 20 | STATE AUTO FINL CORP | COM | 1.32% | $979,000 | 19.2K |
| 21 | CRVSCORVUS PHARMACEUTICALS INChistory → | COM | 1.28% | $949,000 | 196.2K |
| 22 | SOFTWARE ACQUISITN GRP INC I | UNIT 03/01/2028 | 1.24% | $919,000 | 91.0K |
| 23 | FEZSPDR INDEX SHS FDShistory → | EURO STOXX 50 | 1.22% | $906,000 | 20.0K |
| 24 | LYDALL INC | COM | 1.17% | $870,000 | 14.0K |
| 25 | GPXGP STRATEGIES CORPhistory → | COM | 1.17% | $866,000 | 41.8K |
| 26 | GLOBAL PARTNER ACQISTN CORP | CL A SHS | 1.17% | $865,000 | 89.2K |
| 27 | HOME PLATE ACQUISITION CORP | UNIT 09/30/2026 | 1.11% | $826,000 | 83.7K |
| 28 | QADBQAD INC | CL B · CL A | 1.11% | $821,000 | 9.4K |
| 29 | AFFIMED N V | COM | 1.09% | $810,000 | 131.0K |
| 30 | CAI INTERNATIONAL INC | COM | 1.01% | $752,000 | 13.4K |
| 31 | SCYNEXIS INC | COM NEW | 1.01% | $746,000 | 140.8K |
| 32 | WELBILT INC | COM | 1.00% | $741,000 | 31.9K |
| 33 | NUANCE COMMUNICATIONS INC | COM | 1.00% | $740,000 | 13.4K |
| 34 | BABAALIBABA GROUP HLDG LTD | SPONSORED ADS | 1.00% | $740,000 | 5.0K |
| 35 | GS ACQUISITION HLDGS CORP II | COM CL A | 0.98% | $726,000 | 71.0K |
| 36 | BACBK OF AMERICA CORP | COM | 0.97% | $722,000 | 17.0K |
| 37 | GANXGAIN THERAPEUTICS INC | COM | 0.96% | $716,000 | 96.2K |
| 38 | FAST ACQUISITION CORP II | CL A | 0.95% | $702,000 | 72.4K |
| 39 | PERSHING SQUARE TONTINE HLDG | COM CL A | 0.90% | $670,000 | 34.0K |
| 40 | AMRYT PHARMA PLC | SPONSORED ADS | 0.83% | $615,000 | 50.9K |
| 41 | AGILE GROWTH CORP | CLASS A ORD · *W EXP 03/09/202 | 0.78% | $581,000 | 87.5K |
| 42 | ACRSACLARIS THERAPEUTICS INC | COM | 0.76% | $567,000 | 31.5K |
| 43 | CONTRAFECT CORP | COM NEW | 0.73% | $544,000 | 134.4K |
| 44 | GRAF ACQUISITION CORP IV | COM | 0.71% | $524,000 | 54.1K |
| 45 | ARCTOS NORTHSTAR ACQUIS CORP | SHS CL A · *W EXP 99/99/999 | 0.68% | $507,000 | 75.1K |
| 46 | TRACON PHARMACEUTICALS INC | COM NEW | 0.68% | $505,000 | 130.5K |
| 47 | EQHAWEQ HEALTH ACQUISITION CORP | COM CL A · *W EXP 02/02/202 | 0.68% | $505,000 | 189.3K |
| 48 | BRICKELL BIOTECH INC | COM | 0.68% | $504,000 | 699.3K |
| 49 | VIACOMCBS INC | CL B | 0.65% | $482,000 | 12.2K |
| 50 | SANBANCO SANTANDER S.A. | ADR | 0.64% | $478,000 | 132.0K |
| 51 | HBANHUNTINGTON BANCSHARES INC | COM | 0.64% | $478,000 | 30.9K |
| 52 | IECIEC ELECTRS CORP NEW | COM | 0.63% | $466,000 | 30.4K |
| 53 | ACTIVISION BLIZZARD INC | COM | 0.63% | $464,000 | 6.0K |
| 54 | XMESPDR SER TR | S&P METALS MNG | 0.62% | $459,000 | 11.0K |
| 55 | BIOTECH ACQUISITION COMPANY | CL A SHS · *W EXP 11/30/202 | 0.61% | $456,000 | 140.0K |
| 56 | RIGEL PHARMACEUTICALS INC | COM NEW | 0.60% | $445,000 | 122.5K |
| 57 | TXNMPNM RES INC | COM | 0.59% | $435,000 | 8.8K |
| 58 | SPYSPDR S&P 500 ETF TR | TR UNIT | 0.58% | $429,000 | 1.0K |
| 59 | CADENCE BANCORPORATION | CL A | 0.56% | $413,000 | 18.8K |
| 60 | GLDSPDR GOLD TR | GOLD SHS | 0.55% | $411,000 | 2.5K |
| 61 | REVOLUTION HEALTHCAR AQ CORP | CLASS A COM | 0.55% | $410,000 | 42.1K |
| 62 | BRIDGETOWN HOLDINGS LTD | COM CL A | 0.54% | $402,000 | 41.0K |
| 63 | TALKTALKSPACE INC | COM | 0.54% | $402,000 | 110.0K |
| 64 | BPBP PLC | SPONSORED ADR | 0.52% | $383,000 | 14.0K |
| 65 | ALTIMETER GROWTH CORP | CL A | 0.52% | $383,000 | 37.5K |
| 66 | WFCWELLS FARGO CO NEW | COM | 0.49% | $362,000 | 7.8K |
| 67 | MOTIVE CAPITAL CORP | SHS CL A | 0.48% | $356,000 | 36.0K |
| 68 | BELLEROPHON THERAPEUTICS INC | COM NEW | 0.47% | $347,000 | 85.5K |
| 69 | COLUMBIA PPTY TR INC | COM NEW | 0.46% | $344,000 | 18.1K |
| 70 | XLRNACCELERON PHARMA INC | COM | 0.46% | $344,000 | 2.0K |
| 71 | MUSTANG BIO INC | COM | 0.45% | $336,000 | 125.0K |
| 72 | JPMJPMORGAN CHASE & CO | COM | 0.44% | $327,000 | 2.0K |
| 73 | REE AUTOMOTIVE LTD | CLASS A ORD SHS | 0.42% | $313,000 | 69.0K |
| 74 | JAWS HURRICANE ACQUISITN COR | UNIT 06/08/2026 | 0.42% | $309,000 | 30.9K |
| 75 | HUMANIGEN INC | COM NEW | 0.41% | $302,000 | 51.0K |
| 76 | LISTED FD TR | ROUNDHILL SPORTS | 0.41% | $301,000 | 10.0K |
| 77 | MSFTMICROSOFT CORP | COM | 0.40% | $297,000 | 1.1K |
| 78 | EVAXION BIOTECH A S | ADS | 0.40% | $296,000 | 30.7K |
| 79 | EENI S P A | SPONSORED ADR | 0.40% | $294,000 | 11.0K |
| 80 | ERICERICSSON | ADR B SEK 10 | 0.39% | $291,000 | 26.0K |
| 81 | FIVNFIVE9 INC | COM | 0.39% | $288,000 | 1.8K |
| 82 | TTENTOTALENERGIES SE | SPONSORED ADS | 0.39% | $288,000 | 6.0K |
| 83 | VACCINEX INC | COM | 0.39% | $286,000 | 132.5K |
| 84 | MAKEMYTRIP LIMITED MAURITIUS | SHS | 0.37% | $272,000 | 10.0K |
| 85 | KANSAS CITY SOUTHERN | COM NEW | 0.37% | $271,000 | 1.0K |
| 86 | VZVERIZON COMMUNICATIONS INC | COM | 0.36% | $270,000 | 5.0K |
| 87 | GMGENERAL MTRS CO | COM | 0.36% | $265,000 | 5.0K |
| 88 | CORNER GROWTH ACQUISITN CORP | UNIT 05/27/2026 | 0.36% | $264,000 | 26.2K |
| 89 | CLARUS THERAPEUTICS HLDNGS I | COM · *W EXP 08/11/202 | 0.35% | $262,000 | 74.5K |
| 90 | BANK COMM HLDGS | COM | 0.35% | $260,000 | 17.2K |
| 91 | COMPUTE HEALTH ACQUISITIN CO | UNIT 99/99/9999 | 0.34% | $256,000 | 25.6K |
| 92 | UFSDOMTAR CORP | COM NEW | 0.34% | $251,000 | 4.6K |
| 93 | CIT GROUP INC | COM NEW | 0.34% | $249,000 | 4.8K |
| 94 | XLFSELECT SECTOR SPDR TR | FINANCIAL | 0.33% | $244,000 | 6.5K |
| 95 | CHECKPOINT THERAPEUTICS INC | COM | 0.31% | $231,000 | 70.0K |
| 96 | NEMNEWMONT CORP | COM | 0.29% | $217,000 | 4.0K |
| 97 | DISCOVERY INC | COM SER A | 0.29% | $213,000 | 8.4K |
| 98 | GOODRICH PETE CORP | COM PAR | 0.27% | $203,000 | 8.6K |
| 99 | VERASTEM INC | COM | 0.27% | $200,000 | 65.0K |
| 100 | MONEYLION INC | CL A · *W EXP 09/22/202 | 0.26% | $191,000 | 89.9K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q4 2022 | Under review | 146 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $78M | 177 | Nov 17, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $84M | 177 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $63M | 165 | May 16, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $78M | 178 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $74M | 160 | Nov 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $73M | 139 | Aug 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $88M | 126 | May 17, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $59M | 89 | Feb 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $46M | 73 | Nov 16, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $37M | 65 | Aug 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $29M | 54 | May 15, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $30M | 41 | Feb 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $35M | 53 | Nov 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $129M | 82 | Aug 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $197M | 101 | May 15, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $157M | 136 | Feb 14, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.